What community activism can achieve – ITPC’s 2017 Annual Review
ITPC is proud to share its 2017 Annual Review, titled What Community Activism Can Achieve. The report highlights our successes, challenges, and...
Read more about What community activism can achieve – ITPC’s 2017 Annual Review
Five years after the Indian Supreme Court’s Novartis verdict
Five years after this landmark decision, the impact is being felt around the world. India’s decision is frequently held up...
Read more about Five years after the Indian Supreme Court’s Novartis verdict
Groups target EU-Mercosur FTA to advance access to health in trade deals
AIDS activists, health activists and civil society organizations in Brazil and Argentina are pushing back against the negative effects of...
Read more about Groups target EU-Mercosur FTA to advance access to health in trade deals
Truvada case shows civil society’s success with pre-grant opposition
The example of Gilead antiretroviral Truvada in Argentina and Brazil shows how civil society efforts to use patent opposition to...
Read more about Truvada case shows civil society’s success with pre-grant opposition
8 videos that explain the tension between HIV activists and Big Pharma
From Hollywood blockbusters, to investigative documentaries, to our own short, satirical animation, here are eight videos that show how the...
Read more about 8 videos that explain the tension between HIV activists and Big Pharma
Fundación GEP opposes patent on HIV drug Tenofovir (TAF) in Argentina
Pharmaceutical patent would block access to HIV medicines. Our partner is opposing the patent application in a bid to make...
Read more about Fundación GEP opposes patent on HIV drug Tenofovir (TAF) in Argentina
Fixing the broken patent system: From Marrakech and back again
Marrakech was home to the signing of the TRIPS Agreement in 1995, an agreement that has been exploited by pharmaceutical...
Read more about Fixing the broken patent system: From Marrakech and back again
Argentina: Patent rejected on hepatitis C drug, sofosbuvir
A decision by the patent office in Argentina (INPI) to reject Gilead’s patent on key hepatitis C drug, sofosbuvir, is...
Read more about Argentina: Patent rejected on hepatitis C drug, sofosbuvir
World AIDS Day 2017: Argentina remains without an effective HIV and hepatitis law
It’s perceived, that due to the lack of political will of the national government and a lack of interest from...
Read more about World AIDS Day 2017: Argentina remains without an effective HIV and hepatitis law
São Paulo protest exposes how Gilead’s actions block access to medicines around the world
In São Paulo, on 31 October 2017, activists from around the world held a protest at the headquarters of...
Read more about São Paulo protest exposes how Gilead’s actions block access to medicines around the world
News items related to: Argentina
See our introduction on Argentina